ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Please note that you are viewing an archived section from 2023 and some content may be unavailable. To unlock all content for 2023, please visit the archives.

Abstract: FR-PO1040

Acyloxyacyl Hydrolase Protects Against Kidney Injury via Inhibition of Tubular CD74-Macrophage Cross-Talk

Session Information

Category: CKD (Non-Dialysis)

  • 2303 CKD (Non-Dialysis): Mechanisms

Authors

  • Wu, Zhenkai, Shanghai Jiao Tong University School of Medicine Affiliated Ninth People's Hospital, Shanghai, China
  • Pan, Yu, Shanghai Jiao Tong University School of Medicine Affiliated Ninth People's Hospital, Shanghai, China
  • Ding, Feng, Shanghai Jiao Tong University School of Medicine Affiliated Ninth People's Hospital, Shanghai, China
Background

Renal tubulointerstitial fibrosis is the final common pathway in the progression of chronic kidney disease (CKD) to end-stage renal disease (ESRD). Acyloxyacyl hydrolase (AOAH) is expressed in renal tubular epithelial cells and other immune cells. Research shows that AOAH plays a critical role in infections and chronic inflammatory diseases. However, its role in kidney injury and fibrosis is unknown.

Methods

AOAH expression was examined in human and mouse kidneys. Single cell RNA sequencing (scRNA-seq) was performed for kidneys from FA-treated wild type (WT) and Aoah-/- mice. Aoah-/- mice and Aoah-/- mice with overexpression of Aoah in kidney were used to determine its role in kidney injury induced by folic acid (FA), unilateral ureteral obstruction (UUO), and lipopolysaccharide (LPS).

Results

AOAH expression was positively correlated with estimated glomerular filtration rate (eGFR) while negatively correlated with the degree of renal fibrosis in human kidney biopsy tissue. AOAH deletion led to exacerbated kidney injury and fibrosis after FA administration, which was reversed by overexpression of Aoah in kidney. scRNA-seq analysis revealed that Aoah-/- mice exhibited increased subpopulation of proximal tubular epithelial cells (PTECs) expressing CD74, even though total PTECs were decreased compared to WT mice after FA treatment. Finally, exacerbated renal inflammation and fibrosis seen in Aoah-/- mice after kidney injury was attenuated via administration of ISO-1, an inhibitor of macrophage inhibition factor (MIF) and CD74 binding.

Conclusion

AOAH plays a protective role in renal inflammation and fibrosis by inhibiting renal tubular epithelial cells CD74 signaling pathways, which involves tubule-macrophage crosstalk. Targeting kidney AOAH represents a promising strategy to prevent renal fibrosis progression.